Company Search:
Advanced Search
Sponsored Links
Sanofi S.A. - ADR Company Snapshot
Sanofi S.A. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other companies in this sector in the United States: Merck & Co. , Inc. (2015 sales of $39.50 billion of which 88% was Merck Pharmaceutical), Pfizer Inc. ($48.85 billion of which 44% was Operating Segment-Global Established Pha), and GlaxoSmithKline plc ($36.48 billion of which 59% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2015, sales at Sanofi S.A. were $38.45 billion. This is a decrease of 14.6% versus 2014, when the company's sales were $45.04 billion. The sales level in 2015 was fairly close to the level five years ago: in 2010, Sanofi S.A. had sales of $40.11 billion.
  Stock Performance Chart for Sanofi S.A. - ADR
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 37.75
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks -1.6%  
4 Weeks -10.8%   52 Weeks -26.1%  
Sanofi S.A. - ADR Key Data:
  Ticker: SNY Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 38,449,939,950
(Year Ending Jan 2016).
Employees: 115,631
  Currency: U.S. Dollars Market Cap: 97,168,931,332
  Fiscal Yr Ends: December Shares Outstanding: 2,574,011,426
  Share Type: Actions Ordinaires Closely Held Shares: 269,848,712
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.